Logo image of URE.CA

UR-ENERGY INC (URE.CA) Stock Fundamental Analysis

TSX:URE - Toronto Stock Exchange - CA91688R1082 - Common Stock - Currency: CAD

1.12  -0.06 (-5.08%)

Fundamental Rating

3

URE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of URE is average, but there are quite some concerns on its profitability. While showing a medium growth rate, URE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year URE has reported negative net income.
In the past year URE has reported a negative cash flow from operations.
In the past 5 years URE always reported negative net income.
In the past 5 years URE always reported negative operating cash flow.
URE.CA Yearly Net Income VS EBIT VS OCF VS FCFURE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

URE has a worse Return On Assets (-24.91%) than 74.41% of its industry peers.
With a Return On Equity value of -37.00%, URE is not doing good in the industry: 72.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -24.91%
ROE -37%
ROIC N/A
ROA(3y)-22.39%
ROA(5y)-20.85%
ROE(3y)-36.14%
ROE(5y)-36.97%
ROIC(3y)N/A
ROIC(5y)N/A
URE.CA Yearly ROA, ROE, ROICURE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for URE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
URE.CA Yearly Profit, Operating, Gross MarginsURE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

5

2. Health

2.1 Basic Checks

URE does not have a ROIC to compare to the WACC, probably because it is not profitable.
URE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, URE has more shares outstanding
The debt/assets ratio for URE has been reduced compared to a year ago.
URE.CA Yearly Shares OutstandingURE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
URE.CA Yearly Total Debt VS Total AssetsURE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 0.29, we must say that URE is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of URE (0.29) is worse than 60.19% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that URE is not too dependend on debt financing.
URE has a better Debt to Equity ratio (0.01) than 80.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.29
ROIC/WACCN/A
WACC10.26%
URE.CA Yearly LT Debt VS Equity VS FCFURE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 4.83 indicates that URE has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.83, URE belongs to the best of the industry, outperforming 91.00% of the companies in the same industry.
URE has a Quick Ratio of 3.70. This indicates that URE is financially healthy and has no problem in meeting its short term obligations.
URE has a Quick ratio of 3.70. This is amongst the best in the industry. URE outperforms 89.57% of its industry peers.
Industry RankSector Rank
Current Ratio 4.83
Quick Ratio 3.7
URE.CA Yearly Current Assets VS Current LiabilitesURE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

URE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.80%, which is quite impressive.
The Revenue has grown by 200.12% in the past year. This is a very strong growth!
URE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.88% yearly.
EPS 1Y (TTM)25.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)200.12%
Revenue growth 3Y1090.03%
Revenue growth 5Y0.88%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, URE will show a very strong growth in Earnings Per Share. The EPS will grow by 34.24% on average per year.
The Revenue is expected to grow by 44.12% on average over the next years. This is a very strong growth
EPS Next Y74.75%
EPS Next 2Y50.91%
EPS Next 3Y34.18%
EPS Next 5Y34.24%
Revenue Next Year-12.43%
Revenue Next 2Y75.41%
Revenue Next 3Y69.95%
Revenue Next 5Y44.12%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
URE.CA Yearly Revenue VS EstimatesURE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M
URE.CA Yearly EPS VS EstimatesURE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for URE. In the last year negative earnings were reported.
URE is valuated rather expensively with a Price/Forward Earnings ratio of 17.19.
URE's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of URE to the average of the S&P500 Index (22.15), we can say URE is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 17.19
URE.CA Price Earnings VS Forward Price EarningsURE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
URE.CA Per share dataURE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
URE's earnings are expected to grow with 34.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.91%
EPS Next 3Y34.18%

0

5. Dividend

5.1 Amount

URE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UR-ENERGY INC

TSX:URE (5/30/2025, 7:00:00 PM)

1.12

-0.06 (-5.08%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07
Inst Owners83.84%
Inst Owner ChangeN/A
Ins Owners0.82%
Ins Owner ChangeN/A
Market Cap408.60M
Analysts80
Price Target2.37 (111.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-246.53%
Min EPS beat(2)-494.06%
Max EPS beat(2)0.99%
EPS beat(4)2
Avg EPS beat(4)-197.52%
Min EPS beat(4)-494.06%
Max EPS beat(4)0.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-48.08%
Min Revenue beat(2)-100%
Max Revenue beat(2)3.84%
Revenue beat(4)2
Avg Revenue beat(4)-35.31%
Min Revenue beat(4)-100%
Max Revenue beat(4)3.84%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.7%
PT rev (3m)-17.7%
EPS NQ rev (1m)50%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)-21.43%
Revenue NQ rev (1m)-12.41%
Revenue NQ rev (3m)-12.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-35.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.19
P/S 8.77
P/FCF N/A
P/OCF N/A
P/B 2.4
P/tB 2.4
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)0.07
Fwd EY5.82%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.13
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.91%
ROE -37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.39%
ROA(5y)-20.85%
ROE(3y)-36.14%
ROE(5y)-36.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 370.53%
Cap/Sales 35.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.83
Quick Ratio 3.7
Altman-Z 0.29
F-Score2
WACC10.26%
ROIC/WACCN/A
Cap/Depr(3y)127.22%
Cap/Depr(5y)82.73%
Cap/Sales(3y)1196.12%
Cap/Sales(5y)1907.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y74.75%
EPS Next 2Y50.91%
EPS Next 3Y34.18%
EPS Next 5Y34.24%
Revenue 1Y (TTM)200.12%
Revenue growth 3Y1090.03%
Revenue growth 5Y0.88%
Sales Q2Q%N/A
Revenue Next Year-12.43%
Revenue Next 2Y75.41%
Revenue Next 3Y69.95%
Revenue Next 5Y44.12%
EBIT growth 1Y-42.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.62%
EBIT Next 3Y49.08%
EBIT Next 5Y35.54%
FCF growth 1Y-349.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-304.25%
OCF growth 3YN/A
OCF growth 5YN/A